Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSII
1901
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.8M | ﹤0.01% |
90,400
-8,500
| -9% | -$169K |
|
1902
Gogo Inc
GOGO
$1.31B
| $1.79M | ﹤0.01% |
123,600
-16,300
| -12% | -$236K |
|
1903
Hawkins
HWKN
$3.62B
| $1.79M | ﹤0.01% |
40,788
-4,800
| -11% | -$210K |
|
1904
Credo Technology Group
CRDO
$28B
| $1.78M | ﹤0.01% |
188,716
-22,300
| -11% | -$210K |
|
|
CSR
1905
Centerspace
CSR
$979M
| $1.78M | ﹤0.01% |
32,500
-4,600
| -12% | -$251K |
|
1906
Marcus & Millichap
MMI
$1.26B
| $1.77M | ﹤0.01% |
55,200
-7,500
| -12% | -$241K |
|
1907
Petco
WOOF
$970M
| $1.77M | ﹤0.01% |
196,800
-23,300
| -11% | -$210K |
|
1908
Kimbell Royalty Partners
KRP
$1.26B
| $1.77M | ﹤0.01% |
116,100
-13,900
| -11% | -$212K |
|
1909
Avidity Biosciences
RNA
$5.76B
| $1.76M | ﹤0.01% |
114,800
-19,600
| -15% | -$301K |
|
1910
MRC Global
MRC
$1.23B
| $1.75M | ﹤0.01% |
180,549
-21,300
| -11% | -$207K |
|
1911
Green Dot
GDOT
$751M
| $1.75M | ﹤0.01% |
102,100
-14,200
| -12% | -$244K |
|
1912
International Money Express
IMXI
$430M
| $1.75M | ﹤0.01% |
68,000
-9,300
| -12% | -$240K |
|
|
BDN
1913
Brandywine Realty Trust
BDN
$789M
| $1.75M | ﹤0.01% |
370,300
-44,000
| -11% | -$208K |
|
|
SII
1914
Sprott
SII
$1.8B
| $1.75M | ﹤0.01% |
47,975
-5,500
| -10% | -$201K |
|
|
RPT
1915
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.75M | ﹤0.01% |
184,000
-21,700
| -11% | -$206K |
|
1916
Aehr Test Systems
AEHR
$792M
| $1.75M | ﹤0.01% |
56,400
-6,600
| -10% | -$205K |
|
1917
Twist Bioscience
TWST
$1.53B
| $1.75M | ﹤0.01% |
115,900
-13,400
| -10% | -$202K |
|
1918
Fluence Energy
FLNC
$917M
| $1.75M | ﹤0.01% |
86,300
-10,300
| -11% | -$209K |
|
1919
QuinStreet
QNST
$930M
| $1.75M | ﹤0.01% |
110,000
-13,500
| -11% | -$214K |
|
1920
Ardelyx
ARDX
$1.59B
| $1.74M | ﹤0.01% |
+364,200
| New | +$1.74M |
|
|
DCPH
1921
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.74M | ﹤0.01% |
112,700
+15,900
| +16% | +$246K |
|
1922
Golden Entertainment
GDEN
$638M
| $1.74M | ﹤0.01% |
40,000
-4,700
| -11% | -$204K |
|
1923
Geron
GERN
$810M
| $1.74M | ﹤0.01% |
801,900
-19,100
| -2% | -$41.4K |
|
1924
OneSpaWorld
OSW
$2.24B
| $1.74M | ﹤0.01% |
145,100
-16,500
| -10% | -$198K |
|
1925
Rhythm Pharmaceuticals
RYTM
$6.39B
| $1.74M | ﹤0.01% |
97,300
-600
| -0.6% | -$10.7K |
|